George B. Abercrombie, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 74,000 shares at $15.09 ($1.1M) on 2021-09-10, disclosed to the SEC on 2021-09-14.
Open-market sale of $1.1M BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2021-11-17 | $61K | — | Filing → |
| BCRX | SELL | 2021-09-17 | $75K | — | Filing → |
| BCRX | SELL | 2021-07-19 | $78K | — | Filing → |